Heidelberg Pharma AG Statistics
Total Valuation
LON:0QW5 has a market cap or net worth of GBP 180.82 million. The enterprise value is 152.19 million.
Market Cap | 180.82M |
Enterprise Value | 152.19M |
Important Dates
The last earnings date was Thursday, July 10, 2025.
Earnings Date | Jul 10, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 46.60M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | +4.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 9.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 51.33 |
PB Ratio | 11.60 |
P/TBV Ratio | 22.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.75 |
EV / Sales | 42.10 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -6.64 |
Financial Position
The company has a current ratio of 7.74, with a Debt / Equity ratio of 0.01.
Current Ratio | 7.74 |
Quick Ratio | 5.64 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.00 |
Interest Coverage | -5,400.22 |
Financial Efficiency
Return on equity (ROE) is -78.11% and return on invested capital (ROIC) is -56.21%.
Return on Equity (ROE) | -78.11% |
Return on Assets (ROA) | -25.08% |
Return on Invested Capital (ROIC) | -56.21% |
Return on Capital Employed (ROCE) | -48.08% |
Revenue Per Employee | 31,734 |
Profits Per Employee | -176,810 |
Employee Count | 105 |
Asset Turnover | 0.06 |
Inventory Turnover | 0.04 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +82.64% in the last 52 weeks. The beta is -0.28, so LON:0QW5's price volatility has been lower than the market average.
Beta (5Y) | -0.28 |
52-Week Price Change | +82.64% |
50-Day Moving Average | 3.97 |
200-Day Moving Average | 3.33 |
Relative Strength Index (RSI) | 49.54 |
Average Volume (20 Days) | 248 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0QW5 had revenue of GBP 3.52 million and -19.63 million in losses. Loss per share was -0.42.
Revenue | 3.52M |
Gross Profit | 3.08M |
Operating Income | -22.71M |
Pretax Income | -19.63M |
Net Income | -19.63M |
EBITDA | -22.09M |
EBIT | -22.71M |
Loss Per Share | -0.42 |
Balance Sheet
The company has 28.00 million in cash and 102,918 in debt, giving a net cash position of 27.90 million.
Cash & Cash Equivalents | 28.00M |
Total Debt | 102,918 |
Net Cash | 27.90M |
Net Cash Per Share | n/a |
Equity (Book Value) | 15.59M |
Book Value Per Share | 0.33 |
Working Capital | 36.08M |
Cash Flow
In the last 12 months, operating cash flow was -22.55 million and capital expenditures -379,465, giving a free cash flow of -22.93 million.
Operating Cash Flow | -22.55M |
Capital Expenditures | -379,465 |
Free Cash Flow | -22.93M |
FCF Per Share | n/a |
Margins
Gross Margin | 87.55% |
Operating Margin | -644.66% |
Pretax Margin | -557.16% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LON:0QW5 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | n/a |
Earnings Yield | -10.85% |
FCF Yield | -12.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.
Last Split Date | Nov 7, 2017 |
Split Type | Forward |
Split Ratio | 1.0464082038 |
Scores
LON:0QW5 has an Altman Z-Score of -6.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -6.59 |
Piotroski F-Score | 2 |